This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Phibro Animal Health Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 04:35 PM
Transcript : Phibro Animal Health Corporation Presents at Bank of America 2024 Animal Health Virtual Summit, Feb-29-2024 10:00 AM
Transcript : Phibro Animal Health Corporation, Q2 2024 Earnings Call, Feb 08, 2024
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q2 EPS $0.33, vs. Street Est of $0.28 MT
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Reports Q2 Revenue $249.9M, vs. Street Est of $240.9M MT
Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024 CI
Phibro Animal Health Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on March 27, 2024 CI
Phibro Animal Health Corporation Announces Chief Financial Officer Changes, Effective February 9, 2024 CI
Morgan Stanley Trims Price Target on Phibro Animal Health to $16 From $17, Maintains Equalweight Rating MT
Transcript : Phibro Animal Health Corporation, Q1 2024 Earnings Call, Nov 09, 2023
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Reports Q1 EPS $0.14, vs. Street Est of $0.23 MT
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q1 Revenue $231.3M, vs. Street Est of $242M MT
Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 CI
Phibro Animal Health Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Phibro Animal Health Defends Use of Swine Medicine Following FDA Move to Withdraw Approval MT
Phibro Animal Health Corporation Reiterates Safety of Mecadox and Intent to Defend its Use for Customers CI
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on December 20, 2023 CI
Phibro Animal Health Corporation Announces Chief Financial Officer Changes CI
Phibro Animal Health CFO Damian Finio to Step Down; Richard Johnson to Serve as Interim CFO MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $17 From $18, Maintains Equal-Weight Rating MT
Transcript : Phibro Animal Health Corporation, Q4 2023 Earnings Call, Aug 31, 2023
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Reports Q4 Revenue $255M, vs. Street Est of $256.1M MT
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Reports Q4 EPS $0.38, vs. Street Est of $0.38 MT
Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 CI
Chart Phibro Animal Health Corporation
More charts
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
13.04 USD
Average target price
10.75 USD
Spread / Average Target
-17.56%
Consensus
  1. Stock Market
  2. Equities
  3. PAHC Stock
  4. News Phibro Animal Health Corporation
  5. Phibro Animal Health : Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q2 EPS $0.34, vs. Street Est of $0.28